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To examine whether Ifi 200 genes are involved in antiviral state induction by IFNs we expressed mutant forms capable of
inactivating the endogenous p204 and analyzed replication of both RNA and DNA viruses following IFN-a treatment.
Inactivation of p204 does not impair replication of vesicular stomatitis virus, encephalomyocarditis virus, ectromelia virus,
and herpes simplex virus 1 and does not alter an IFN-a induced antiviral state. By contrast, in cells lacking functional p204,
mouse cytomegalovirus (MCMV) replication is strongly inhibited and is not further modulated by IFN-a. These results suggest
that p204, a member of the Ifi 200 gene family, is not involved in the IFN-a-induced antiviral activity against some RNA or DNA
viruses, but is required by MCMV for its replication. © 1999 Academic Press
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aIFN binding to specific cell surface receptors activates
family of transcription factors termed signal transduc-
rs and activators of transcription, or STATs (26), that
eside outside the nucleus in untreated cells, but be-
ome activated, multimerize, and translocate into it upon
timulation with IFNs. Here, by recognizing discrete cis-
cting regulatory DNA sequences they stimulate tran-
cription of so-called IFN-inducible genes or ISGs (7).
he ensuing transient antiviral state is thought to result
rom the concerted action of a large number of IFN-
nduced proteins. Defining the relative contributions of
hese proteins is therefore a formidable task. To date, the
hysiological roles of only a few IFN-induced proteins
ave been resolved (e.g., Mx, PKR, 29-59 oligoadenylate-
ynthetase) (16, 26).
One family, designated Ifi 200, includes the p202, p203,
204, and D3 proteins (20) and their human homologues,
NDA (myeloid nuclear differentiation antigen) (2), Ifi 16
27), and AIM2 (8). It is encoded by a cluster of six or
ore structurally related murine genes in the q21–q23
egion of chromosome 1 (gene 200 cluster) and appears
o be transcriptionally activated by IFNs both in vitro and
n vivo (17, 20). These proteins share one or two partially
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Public Health and Microbiology, Medical
chool of Torino, Via Santena 9, 10126, Torino, Italy. Fax: 0039-011-l636436. E-mail: Landolfo@molinette.unito.it.
1onserved 200-amino-acid segments, designated do-
ain a and domain b, respectively, and at least four of
hem are nuclear.
The 202 gene, the best defined member of the murine
amily, encodes a 52-kDa phosphoprotein that increases
0- to 30-fold in cultured cells in response to IFN-a and
ranslocates into the nucleus after a few hours. Here,
202 binds to both pRB and the transcription factors E2F,
53, AP-1, c-Fos, c-Jun, and NFkB and inhibits their ac-
ivity (4–6, 22). When p202 was stably transfected in cells,
he 202 transfectants either expressed low p202 levels or
ost the transgene after some time, indicating that cells
o not tolerate high levels of p202 expression (18).
p204 is a 72-kDa phosphoprotein that, like p202, in-
reases several-fold upon treatment with IFN-a and then
ranslocates into the nucleus (19). The 204 protein func-
ions as a growth suppressor in sensitive cell lines, as
etermined by cell focus assays. Transient p204 overex-
ression through a heavy-metal-inducible promoter in
ouse embryo fibroblasts (MEF) lacking the endoge-
ous p204 arrests cell growth by accumulating cells at
he G1/S border (19). The 204 protein contains two
XCXE motifs that are potential sites for binding to the
etinoblastoma gene product pRB. One motif is in the first
00-amino-acid domain at position 423–427, and the
ther is in the second domain at position 611–615. Re-
ent results from our laboratory indicate that both motifs
re required for p204 antiproliferative activity (unpub-ished observations). Moreover, in vivo studies by West-
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2 RAPID COMMUNICATIONrn blotting and immunohistochemistry analysis demon-
trated that, like the human homologue Ifi 16, p204 is
onstitutively expressed in myeloid cells and selectively
nduced by the synthetic double-stranded RNA, poly(rI:
C), in monocyte/macrophage-like cells (12). From these
bservations a potential role of p204 in cell cycle control
nd terminal differentiation has been inferred. By con-
rast, the role of the Ifi 200 genes in the induction of
ntiviral state by IFNs is still an open question.
As a first attempt to verify whether p204 does play any
ole in the IFN-mediated antiviral state induction, MEFs
ere transfected with the expression vector pRcRSV
arboring both a C-terminal deletion mutant and a point
utant form of the 204 cDNA. A schematic representa-
ion describing the proteins encoded by each plasmid is
resented in Fig. 1A. MEF3T3 cells were chosen for
ransfection because they do express p204 at high levels
pon IFN induction, but not p202, behaving as an excel-
ent cellular system for monitoring the antiviral activity
ediated by the 204 protein. The plasmids harboring
ither of the mutated 204 proteins, p204DRB or
204dmRB, together with the empty vector were trans-
ected in MEF3T3 cells, and pooled populations of neo-
ycin-resistant clones were established and designated
204DMEF for p204DRB and p204dmMEF for p204dmRB
ransfection. Expression of either transfected mutants or
ndogenous p204 was assessed by both Western blot-
ing and immunofluorescence analysis. The mutant
orms were detected by using anti-hemagglutinin (anti-
A) monoclonal antibodies, whereas the endogenous
04 protein was detected with a rabbit polyclonal anti-
FIG. 1. (A) Schematic diagram of wild-type and mutant 204 proteins.
B binding motifs are indicated. The seven vertical bars at the N-termi
del 640-568) harbors only the LXCXE domain present in domain a; the
-terminal deletion up to amino acid 568 and the point mutation from g
unctional RB binding domain. Both mutant proteins have been cloned in
ith an in-frame fusion at the C-terminus with the HA epitope, transfecte
lones were named p204DMEF (for p204DRB transfection) and p204dm
he empty vector (pRcRSV) are indicated as neoMEF. (B) Western blot
mounts (50 mg) of total protein extracts were separated on an 8.5%
ndogenous 204 protein from neoMEF untreated or treated with IFN-a
he expression levels of p204 mutants were monitored with anti-HA mo
ontrol.erum raised against the C-terminal moiety, as previ- Musly described (12). Figure 1B shows that both mutated
roteins are expressed at high levels. As expected, p204
evels were almost undetectable in the control cells,
ransfected with the empty vector and designated
eoMEF, but sharply increased upon IFN-a treatment.
FN treatment did not modify the expression levels of the
utated p204 (data not shown).
Immunofluorescence staining analysis by confocal la-
er scanning microscopy showed in untreated neoMEF a
iffuse nuclear and cytoplasmic p204 staining (Fig. 2a),
hereas upon IFN-a treatment for 24 h staining was
redominantly nuclear (Fig. 2b). The mutated 204 pro-
eins showed a subcellular distribution similar to that of
he endogenous protein (Figs. 2c and 2d), demonstrating
hat the introduced mutations do not interfere with their
ellular localization.
To evaluate whether the mutant p204 forms had any
ominant-negative effects, neoMEF and cells trans-
ected with either of the p204 mutant forms, p204DMEF
r p204dmMEF, were virus infected and assayed for
ntiviral state induction upon IFN treatment. The viruses
ested were representative of four families as follows:
icornaviridae (encephalomyocarditis virus, EMCV);
habdoviridae (vesicular stomatitis virus, VSV serotype
ndiana); a- and b-Herpesviridae (herpes simplex virus,
SV-1, and mouse cytomegalovirus, MCMV, respec-
ively); Poxviridae (Ectromelia virus, Ectr.V). They were all
ytopathic and, with the sole exception of MCMV, lysed
usceptible MEF3T3 cells within 48 h. Titers of the sam-
les taken at 24 h postinfection (p.i.) with VSV and EMCV,
t 36 h p.i. with HSV-1 and Ectr.V, and at 144 h p.i. with
nserved 200-amino-acid domain (type a and type b segment) and the
icate the heptamer repeats. The C-terminal deletion mutant p204DRB
n encoded by the construct indicated as p204dmRB harbors both the
acid to lysine at position 427; therefore the resulting protein lacks any
cRSV expression vector, harboring the drug resistance (G418) marker,
EF3T3 cells, and the resulting pooled population of neomycin-resistant
or p204dmRB transfection), respectively. Control cells transfected with
s of endogenous or mutants p204 protein in transfected MEFs. Equal
AGE gel and blotted onto a PVDF membrane. The presence of the
was detected with an affinity-purified rabbit polyclonal antibody (left).
al antibodies (right). A Western blot of a-actin was included as internalThe co
nus ind
protei
lutamic
the pR
d in M
MEF (f
analysi
SDS–P
for 24 h
noclonCMV are shown in Fig. 3. Following IFN treatment,
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3RAPID COMMUNICATIONeoMEF showed a high degree of resistance to both
NA and DNA viruses: titers were indeed more than
00-fold lower than those of the untreated cells. These
esults indicate that neoMEF cells are permissive to all
ive viruses and fully responsive to IFN antiviral activity. A
ifferent picture emerged with p204DMEF and
FIG. 2. Localization of endogenous or mutant p204 proteins in transfe
ith IFN-a for 24 h (b), was immunostained with affinity-purified anti-
onoclonal antibodies against the HA peptide (c and d). FITC-conjugate
ntibodies, respectively.204dmMEF cells. Both were fully susceptible before aFN treatment to RNA viruses, i.e., EMCV and VSV, and to
wo of the DNA viruses, i.e., HSV-1 and Ectromelia virus.
s expected, a significant decrease in virus titer (more
han 2 logs) was observed when the transfectants were
reated with IFN-a, indicating that expression of the dom-
nant-negative mutants did not interfere with its antiviral
EFs by indirect immunofluorescence. NeoMEF, untreated (a) or treated
abbit antibodies; p204D or p204dm MEFs were immunostained with
abbit or mouse antibodies were used to detect the anti-p204 or anti-HActed M
p204 r
d anti-rctivity. By contrast, when untreated p204DMEF or
p
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4 RAPID COMMUNICATION204dmMEF was infected with MCMV, a significant de-
rease in virus yield was observed (1.3 3 103 and 9.5 3
2
FIG. 3. Virus replication in neo, p204D, or p204dm MEF cells. Cells w
picornavirus (EMCV), a poxvirus (Ectromelia, Ectr.V), an a-herpesviru
sed, but for simplicity only the results obtained with the m.o.i. of 1 P
ndicated in the text for each virus were evaluated on Swiss MEF and0 PFU, respectively) compared to that obtained with (ntreated neoMEF (4.1 3 106 PFU). When cells were
reated with IFN-a no significant decrease in virus yield
2 2
cted with the following viruses: a rhabdovirus (VSV serotype Indiana),
-1), a b-herpesvirus (CMV). m.o.i. ranging from 0.1 to 2 PFU/cell were
are reported. The viral titers in the culture supernatants at the times
ields are plotted.ere infe
s (HSV
FU/cell8.9 3 10 PFU for p204DMEF and 6.4 3 10 PFU for
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5RAPID COMMUNICATION204dmMEF) was observed, suggesting that inactivation
f endogenous p204 impairs MCMV replication. Finally,
inetics experiments demonstrated that at later time
oints, i.e., 168 and 192 h, MCMV production from
204DMEF and p204dmMEF slightly increased (values
anging between 104 and 105 PFU) without reaching the
evels of virus yields observed with neoMEFs at the
ame time points (values ranging between 106 and 107
FU) (data not shown).
The lower MCMV yields observed in MEFs transfected
ith the dominant-negative mutants could be caused by
ecreased virus levels adsorbed by these cells at the
arly phases of infection. To rule out this possibility, the
mounts of viral genome adsorbed were measured by a
ompetitive PCR assay that allows the absolute quanti-
ication of small amounts of viral DNA by its coamplifi-
ation with known amounts of added competitor DNA.
he amplification target was a region of the MCMV IE1
ene spanning from exon 2 (5890 nt) to exon 4 (6529 nt),
enerating an amplification product of 639 bp (Fig. 4A)
11). A DNA fragment of the same sequence as the target
iral DNA (except for an insertion in the middle to enable
dentification after gel electrophoresis) was used as
ompetitor (11). As shown in Fig. 4B, as the number of
ompetitor molecules added increases, the ratio be-
ween the upper and the lower band increases. Equiva-
ence between genomic DNA from infected neo, p204D,
nd p204dm MEFs and competitor is obtained at the
ame concentration of 4 3 104 competitor DNA mole-
ules, indicating that expression of the dominant-nega-
ive mutants does not affect the MCMV adsorption, but
ather impairs subsequent phases of the infection.
IFN antiviral activity has been extensively studied: de-
ending on the cell type and the virus, it affects viral
enetration and uncoating, transcription, translation, and
ssembly of progeny viruses (16). The most convincing
emonstration of the role of the IFN-inducible 29-
9(A)synthetase/RNase L pathway in antiviral action
omes from experiments in which expression vectors
ontaining the cDNAs for the human 40-kDa isoenzyme
r the mouse 43-kDa isoenzyme were transfected into
ifferent cell types. EMCV or mengo virus replicated
oorly in these cells, whereas replication of VSV and
SV-2 was not affected (3). Protection of cells against
uman immunodeficiency virus (HIV) infection by the
xpression of 29-59(A) synthetase has also been reported
24). Another IFN-inducible protein, namely the protein
inase PKR, seems to be a central component in the
ntiviral resistance to picornaviruses and vaccinia virus.
eplication of EMCV or vaccinia virus was indeed re-
uced in mouse 3T3 cells by expression of the cDNA
ncoding wild-type PKR, but not by expression of the
KR(1-551)K296R catalytic subdomain II point mutant,
hich lacks kinase activity (10). By far the most progress
as been made with the Mx system as mediator of
ntiviral IFN activity (25). Swiss 3T3 cells transfected with scDNA encoding the human MxA display a high degree
f resistance to influenza virus and VSV, but not to two
icornaviruses, to a togavirus, or to HSV-1. MxA protein
nterfered with intracytoplasmic transport of viral mRNAs,
iral protein synthesis, and translocation of newly syn-
hesized viral protein to the cell nucleus.
We have previously demonstrated that, like its human
ounterpart, MCMV up-regulates the cellular NF-kB ac-
ivity needed for initial induction of the IE genes and
rogression of its replication a few hours after infection
14). By contrast, IFN-a inhibits MCMV IE gene enhancer
ctivity by mechanisms that decrease the availability of
irus-induced NF-kB transcriptionally active in the nuclei
f infected cells (13).
The main conclusion from the experiments presented
ere is that expression of mutant 204 proteins devoid of
ne or both of the RB binding domains can interfere with
he MCMV multiplication cycle but does not affect IFN
ntiviral activity. Our results clearly indicate that the IFN-
nducible protein p204 is somehow related to MCMV
eplication. How MCMV exploits p204 is not known,
hough one model can be envisaged. It has been dem-
nstrated that Ifi 200 genes are more related to control of
he cell cycle than control of virus replication (19; unpub-
ished results) and that HCMV infection arrests the cell
ycle and alters the steady-state levels of several pro-
eins involved in its regulation (1, 9, 15, 21). The present
inding that inactivation of p204 by dominant-negative
utants deregulates the cell cycle and renders cells
ntrinsically resistant to MCMV replication might there-
ore suggest that MCMV exploits p204 to regulate the
ell cycle and consequently its replication. Further sup-
ort for this hypothesis comes from the finding that
CMV transcriptionally activates p204 expression a few
ours after its adsorption to the infected cells and tightly
egulates its levels of expression by posttranscriptional
rocesses (unpublished observations).
Mouse embryo fibroblasts (MEF3T3) were kindly pro-
ided by T. Upton (Dana-Farber Cancer Institute) (23) and
ultured in Dulbecco’s modified Eagle’s medium supple-
ented with 10% fetal calf serum (Gibco BRL). Where
ndicated, cells were treated for 24 h with 1000 U/ml of
ecombinant hybrid human IFN-a A/D (sp act 4 3 1028
/mg of protein), used as a source of murine IFN-a,
ince the antiviral activity is similar in human, bovine,
eline, rat, and mouse cells (28). Transfections were car-
ied out with Lipofectamine Plus (Gibco BRL) as speci-
ied by the manufacturer’s protocol. Briefly, 3 3 105 MEF
ells were transfected with 2 mg of the indicated plasmid
nd stable transfectants were selected by the addition of
00 mg/ml G418 (Gibco BRL), the medium being changed
very 4–5 days until G418-resistant colonies began to
ppear (14–16 days after transfection). Pools of at least
00 colonies were harvested and maintained in G418
election. Expression of the exogenous protein was eval-
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6 RAPID COMMUNICATIONated by Western blotting using the anti-HA-probe mono-
lonal antibody (Boehringer).
The pRcRSV204 vector, which is tagged with a HA
pitope, was constructed by PCR amplification (using Pfu
NA Polymerase, Stratagene) from pSVK3-204 contain-
ng the entire 204 coding region and cloning in the
lunt-ended NotI site of pRcRSV (Invitrogen). Primers
FIG. 4. Competitive PCR to quantify the MCMV particles adsorbed o
ontaining the IE-1 gene, was linearized with SphI cutting exon 3 (6199
G77 indicate the plus and minus primers, respectively (11). (B) Fixe
dsorption were amplified by 35 PCR cycles with increasing amounts (
ower arrows indicate the amplification products for competitor and ge
ndicated on the left. The arrowhead on the bottom indicates the equiva
roducts corresponding to competitor and genomic DNA of the gel wesed to amplify the 204 cDNA were constructed in order co obtain a C-terminal fusion protein with the HA epitope
s follows: N-terminal 59-TCAcaggctggcatagtcagggac-
tcataaggataGATGACCTGCATGTAACTGTGC-39 (where
CA is a stop codon; the HA epitope is in lowercase
etters); C-terminal 59-TCAcaggctggcatagtcagggacgt-
ataaggataCTCTCCACTCACAAATGTCC-39. The 204 RB
inding site mutants were constructed by either oligonu-
p204D, or p204dm MEFs. (A) Plasmid pIE89, derived from pACYC177,
n insert of 84 bp was cloned in this unique restriction site. MG76 and
unts of genomic DNA (1 mg) derived from MEFs after 2 h of MCMV
104 molecules) of competitor DNA for the IE-1 region. The upper and
DNA, respectively. Positions of the molecular mass markers (bp) are
etween genomic DNA and competitor. The bands of the amplification
ntified with Bio-Rad Analyst, Version 1.5.n neo,
) and a
d amo
1–32 3
nomic
lence bleotide-directed mutagenesis or subcloning by stan-
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7RAPID COMMUNICATIONard procedure. To generate pRcRSV204DRB (for brevity
204DRB) (del 640–568), a 220-bp fragment from
RcRSV204 was removed by digestion with ScaI and
eligated. For the construction of pRcRSV204dmRB (for
revity p204dmRB), containing a point mutation in the Rb
inding site at position 427 from E to K, the following two
utagenic oligonucleotides were utilized: MG144,
9-GCAACCAAAGTTAGTGTGTGGAaAACACAGTTTC-
TCAAGATATC-39; MG145, 5-GATATCTTGATGAAACTGT-
TTtTCCACACA CTAACTTTGGTTGC-39. The mutants
enerated are shown schematically in Fig. 1A. All muta-
ions and in-frame junctions were confirmed by sequenc-
ng.
Total cell extracts were prepared by lysing cells in 3%
DS lysis buffer (12). Proteins were separated on a 8.5%
DS–polyacrylamide gel and transferred onto a PVDF
embrane (Amersham), and Western blot analysis was
erformed as previously described (12, 19).
Neo, p204D, and p204dm MEF cells grown on cover-
lips were washed with PBS, fixed with 2% paraformal-
ehyde for 15 min at room temperature, and then washed
gain with PBS. The cells were subsequently permeabil-
zed with 0.2% Triton X-100 for 20 min at 4°C, washed
ith PBS–1% BSA, and incubated with the anti-HA anti-
ody (Boehringer) or the anti-p204 antiserum (12) in PBS
ith 10% DCS for 1 h at room temperature. After being
ashed with PBS–1% BSA, 0.05% Tween 20, the cells
ere incubated with FITC-conjugated anti-mouse or anti-
abbit secondary antibody in PBS–1% BSA for 1 h. Finally,
overslips washed with PBS were soaked with 1 mg/ml
ropidium iodide for 3 min, washed again with PBS,
nd mounted in 90% glycerol, 2.5 g/L diaza-
icyclo[2.2.2]octane (Sigma) in PBS. Immunofluores-
ence microscopy was performed on an Olympus IX70
nverted confocal laser scanning microscope, equipped
ith a krypton–argon ion laser (488/568 nm).
To assess the antiviral state, neo, p204D, and p204dm
EFs, untreated or treated with IFN-a (1 3 103 U/ml) for
4 h, were infected with EMCV, vesicular stomatitis virus
VSV serotype Indiana), Ectr.V, HSV-1, and MCMV, at m.o.i.
anging from 0.1 to 2 PFU/cell, but for simplicity only one
.o.i. (1 PFU/cell) is reported for each virus. The viral
iters in the culture supernatants were measured on
wiss mouse embryo fibroblasts by the plaque-forming
ssay and are expressed as log10 PFU/ml.
Fixed amounts of genomic DNA (1 mg) extracted 2 h
fter virus adsorption from neo, p204D, and p204dm
EFs infected with MCMV at an m.o.i. of 0.1 PFU/cell
ere amplified by 35 PCR cycles with increasing
mounts (from 1 3 104 to 3.2 3 105 molecules) of com-
etitor DNA for the IE-1 region (11). The monolayers were
xtensively washed before DNA extraction to avoid co-
mplification of DNA from viral particles nonspecifically
ssociated with cells. The bands of the amplification
roducts corresponding to competitor and genomic DNAf the gel were quantified with the Bio-Rad Analyst,
ersion 1.5.
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